This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Maruho Co., Ltd.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Hiroki Sakiyama - Innovator in Transdermal Administration
Introduction
Hiroki Sakiyama is a notable inventor based in Kyoto, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of topical agents for transdermal administration. His innovative approach aims to enhance the effectiveness of drug delivery through the skin.
Latest Patents
Hiroki Sakiyama holds a patent for a topical agent designed for transdermal administration. This invention focuses on improving the transdermal absorbability of cyclosporine, a medication often used for its immunosuppressive properties. The patent describes an external preparation that contains cyclosporine and a ketone, which enhances its absorption through the skin.
Career Highlights
Sakiyama is associated with Maruho Co., Ltd., a company known for its commitment to developing innovative pharmaceutical products. His work at Maruho has allowed him to focus on research and development in the field of dermatology and drug delivery systems.
Collaborations
Throughout his career, Hiroki Sakiyama has collaborated with esteemed colleagues, including Noriaki Kaneda and Tomomi Shigeno. These collaborations have contributed to the advancement of research in transdermal drug delivery and have fostered a productive environment for innovation.
Conclusion
Hiroki Sakiyama's contributions to the field of transdermal administration highlight his role as an innovator in pharmaceuticals. His patent for a cyclosporine external preparation demonstrates his commitment to improving drug delivery methods. His work continues to influence the industry and pave the way for future advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
